Evaluation of the Effectiveness and Use of Anti-Methicillin-Resistant Staphylococcus aureus Agents for Aspiration Pneumonia in Older Patients Using a Nationwide Japanese Administrative Database
Authors:
- Satoru KogaSKSatoru Koga
- Takahiro TakazonoTTTakahiro Takazono
- Takashi KidoTKTakashi Kido
- Keiji MuramatsuKMKeiji Muramatsu
- Kei TokutsuKTKei Tokutsu
- Takatomo TokitoTTTakatomo Tokito
- Daisuke OkunoDODaisuke Okuno
- Yuya ItoYIYuya Ito
- Hirokazu YuraHYHirokazu Yura
- Kazuaki TakedaKTKazuaki Takeda
- Naoki IwanagaNINaoki Iwanaga
- Hiroshi IshimotoHIHiroshi Ishimoto
Open Access
- 27 July 2023
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 11 (8) , 1905
Abstract
Studies indicated potential harm from empirical broad-spectrum therapy. A recent study of hospitalizations for community-acquired pneumonia suggested that empirical anti-methicillin-resistant Staphylococcus aureus (MRSA) therapy was associated with an increased risk of death and other complications. However, limited evidence supports empirical anti-MRSA therapy for older patients with aspiration pneumonia. In a nationwide Japanese database, patients aged ≥65 years on admission with aspiration pneumonia were analyzed. Patients were divided based on presence of respiratory failure and further sub-categorized based on their condition within 3 days of hospital admission, either receiving a combination of anti-MRSA agents and other antibiotics, or not using MRSA agents. An inverse probability weighting method with estimated propensity scores was used. Out of 81,306 eligible patients, 55,098 had respiratory failure, and 26,208 did not. In the group with and without respiratory failure, 0.93% and 0.42% of the patients, respectively, received anti-MRSA agents. In patients with respiratory failure, in-hospital mortality (31.38% vs. 19.03%, p < 0.001), 30-day mortality, and 90-day mortality were significantly higher, and oxygen administration length was significantly longer in the anti-MRSA agent combination group. Anti-MRSA agent combination use did not improve the outcomes in older patients with aspiration pneumonia and respiratory failure, and should be carefully and comprehensively considered.Keywords
Funding Information
- Ministry of Health, Labour, and Welfare, Japan (22AA2003)
This publication has 25 references indexed in Scilit:
- Continuous regional arterial infusion for acute pancreatitis: a propensity score analysis using a nationwide administrative databaseCritical Care, 2013
- Mortality and morbidity after high-dose methylprednisolone treatment in patients with acute cervical spinal cord injury: a propensity-matched analysis using a nationwide administrative databaseEmergency Medicine Journal, 2013
- Systematic Review and Meta-Analysis of Vancomycin-Induced Nephrotoxicity Associated with Dosing Schedules That Maintain Troughs between 15 and 20 Milligrams per LiterAntimicrobial Agents and Chemotherapy, 2013
- Variation in cancer surgical outcomes associated with physician and nurse staffing: a retrospective observational study using the Japanese Diagnosis Procedure Combination DatabaseBMC Health Services Research, 2012
- Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled StudyClinical Infectious Diseases, 2012
- Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging EpidemicClinical Microbiology Reviews, 2010
- Renal function as a predictor of linezolid-induced thrombocytopeniaInternational Journal of Antimicrobial Agents, 2009
- HIGH INCIDENCE OF ASPIRATION PNEUMONIA IN COMMUNITY‐ AND HOSPITAL‐ACQUIRED PNEUMONIA IN HOSPITALIZED PATIENTS: A MULTICENTER, PROSPECTIVE STUDY IN JAPANJournal of the American Geriatrics Society, 2008
- Emergence of Community-Acquired Methicillin-Resistant Staphylococcus aureus USA 300 Clone as the Predominant Cause of Skin and Soft-Tissue InfectionsAnnals of Internal Medicine, 2006
- Hospital-Acquired PneumoniaaChest, 2003